Epilepsy Diagnosis & Treatment Market Research Report - Forecast to 2030

Epilepsy Diagnosis and Treatment Market Research Report, By Type (Idiopathic, Cryptogenic, Symptomatic), Diagnosis (Neurological Exam, Blood Test, Imaging), Treatment (Medication, Surgery) End-User (Hospitals, Clinics) - Forecast Till 2030

ID: MRFR/Pharma/4192-HCR | January 2023 | Region: Global | 90 Pages         

Epilepsy Diagnosis Treatment Market Speak to Analyst Request a Free Sample

Epilepsy Diagnosis and Treatment Market

The epilepsy diagnosis and treatment market size are expected to grow at a CAGR of 14.90% and market value 9130.74 Million during the forecast period 2022-2030.

Segmentation
By Type Idiopathic Cryptogenic Symptomatic
By Diagnosis Neurological Exam Blood Test Imaging
By Treatment Medication Surgery
By End User Hospitals Clinics
Key Players
Companies Profiled   Pfizer Inc. (US)   Siemens Ltd. (Germany)   Johnson & Johnson Services Inc. (US)   UCB Pharma Ltd. (UK)   Natus Medical Incorporated. (US)   Shire (Republic of Ireland)   Abbott (US)   NeuroWave Systems Inc. (US)   GlaxoSmithKline plc (UK)   Medtronic (US)
Drivers
Market Driving Forces   Rise in the investment and funding available for the development of new products
Request a Free Sample

Epilepsy Diagnosis and Treatment Market Overview:


The epilepsy diagnosis and treatment market is expected to reach USD 9130.74 Million by 2030 at 14.90% CAGR during the forecast period 2022-2030. Epilepsy can be understood as a neurological disorder affecting the central nervous system. In such a medical condition, the brain exhibits abnormal functioning and activity, which results in periods of unusual behavioral patterns or seizures. Sometimes, there are conditions like loss of awareness, as well. Temporary confusion, uncontrolled anxiety, uncontrollable jerking movements of the arms and legs, amongst others are some of the prevalent symptoms of the disease.


COVID 19 Analysis


The arrival of the novel coronavirus was worrisome when it took a fatal turn and crossed the international borders in 2020. The World Health Organization intervened to set certain ground rules for the global handling of the diseases with the help of existing healthcare funds and infrastructure that are available in various global regions. The pandemic has been taking the lives of many as the rate of transmission is extremely high and there is no vaccine available that guarantees cent percent protection from the disease. However, the unavailability of the same is an issue that will impact the epilepsy diagnosis and treatment market functions. The pandemic is unfolding in various forms and various waves confirm the same. Hence, to stop the quick spread of the pandemic, the global governments across the world are imposing strict regulations, frameworks, and lockdown. The imposition of lockdown is harming the epilepsy diagnosis and treatment market and business functioning as the manufacturing and production units are unable to meet the market trends and thus, maintain equilibrium amongst the market demand and supply scale.


The global government is increasing its investment and funding in the research and development initiatives and activities along with entering collaborations with various public and private sector units that will help in putting the epilepsy diagnosis and treatment market at a better place in the global market competition especially during the forecast period that will be ending in 2030.


Market Dynamics


Drivers


One of the major factors that are driving the growth of the epilepsy diagnosis and treatment market for the ongoing forecast period that will be ending in 2030 is that there has been a considerable rise in the investment and funding available for the development of new products. There has been a constant change in the taste and preferences of the target audience that has developed a constant need and availability of products and market services that will help in making sure that the emerging demand is met with the supply chain mechanism.


Restraints


However, the epilepsy diagnosis and treatment market analysis shows the development of possible restraints due to which there might be a slowdown in the market functioning which might bar the ability of the market to reach the predicted market revenue for the forecast period of 2022-2030. The target audience that requires these devices needs to shed a huge amount of money to procure these devices. The incomes of various people are different and hence, this affects their purchasing power and spending capacity. There is a high cost of acquisition associated along with the lack of awareness that might restrain the market from growing during the period.


Technology Analysis


There has been a huge technological development and the employment of the same across various series and segments belonging to the market that will play a major role in developing the epilepsy diagnosis and treatment market share and grow as per the predictions during the forecast period between 2021-2028. Also, the huge increase in the target audience that is suffering from various kinds of neurological disorders requires the need for technology and advanced procedures that will help in improving the market stance at the regional and international market scale.


Study Objectives


The epilepsy diagnosis and treatment market analysis help to understand the basis on which the industry leaders and market experts have predicted the CAGR growth and the final revenue quantum of the market during the forecast period of 2022-2030. Also, the market report aims to understand the impact of the pandemic on the functioning of the market to cover the losses and emerge as major competitive players during the forecast period.


To have an idea about the market dynamics that are available to the market in the form of growth, opportunities, restraints, and challenges that will have an overall impact on the epilepsy diagnosis and treatment market and make sure of the presence of an array of attributes that will be responsible for growth during the forecast period. The report also aims to have a deep understanding of the basis of market segmentation and their ability to meet the target audience that will help in making a difference to the revenue collected during the period.


To have a glance at the rising degree of competition amongst the market players in both the domestic and the international epilepsy diagnosis and treatment market and consider the recent developments undertaken by the prominent market players during the forecast period that ends in 2030.


Segment Overview


The market has been segmented based on the following:


Based on the product type:


The segment of the epilepsy diagnosis and treatment market includes idiopathic, cryptogenic, and symptomatic, amongst others.


Based on the market type:


The epilepsy diagnosis and treatment market has been segmented based on the market type and includes neurological exams, blood tests, and imaging for detection.


Based on the material type:


The epilepsy diagnosis and treatment market has been segmented based on the material type and includes medication, surgery, and brain stimulation.


Based on the market end-users:


The market end-users are hospitals, neurology centers, clinics, and home care settings amongst others.


Regional Analysis


Based on the geographical division of the market, the market trend shows that the North American region is likely to establish domination in the market and earn a good epilepsy diagnosis and treatment market revenue. The American region is likely to dominate the global epilepsy diagnosis and treatment market owing to a well-developed healthcare sector, a huge patient population, and an increase in the number of head trauma cases.


Competitive Landscape


There has been a hike in the existing degree of competition as there have been constant efforts rendered by the prominent players of the epilepsy diagnosis and treatment market share followed by the recent developments undertaken by them during the forecast period of 2021-2028. The key market players are stated as follows:



  • Pfizer, Inc. (US)

  • Siemens Ltd. (Germany)

  • Johnson & Johnson Services, Inc. (US)

  • UCB Pharma Ltd. (UK)

  • Natus Medical Incorporated. (US)

  • Shire (Republic of Ireland)

  • Abbott (US)

  • NeuroWave Systems Inc. (US)

  • GlaxoSmithKline plc (UK)

  • Medtronic (US)

  • Novartis International AG (Switzerland)

  • Sanofi S.A. (France)


Recent Developments



  • High chances of development of the Asian Pacific and European companies and region in the regional market are being witnessed. One of the major reasons behind the same is that there has been a huge rise in various kinds of product introductions and improvements that are being coupled with the development and availability of versatile government subsidies in the region which is pushing the market towards growth during the forecast period that ends in 2028.

  • The NK-HealthProtect wireless surge solution has been developed by Nihon Kohden from Japan. This market product is a qualitative mixture of patient monitors, hardware, and software. The major idea behind this development is to be used in the intensive care units of hospitals that have a huge customer footfall.

  • There has been a rapid expansion undergoing in the APAC region for the market functioning during the forecast period. The population of various countries belonging to the APAC region is increasing followed by the increase in epilepsy patients that is giving rise to prevalent awareness regarding treatment choices and strategic decisions that are helping important firms to operate and dwell in this region. Hence, the region is all set to rise at a good rate during the period and subsequently, compete in the international market.


Intended Audience



  • Healthcare service centers and providers

  • Hospitals and clinics

  • Market investors and potential buyers

  • Investors, manufacturers, and producers

  • Healthcare device exporters and importers


Report Overview


The global epilepsy diagnosis and treatment market report discusses various factors that will help the market to grow and the possible restraints that will impact the market. Also, the report will help in understanding the working of the market segments and the rising competition based on the recent developments undertaken by the market players during the forecast period.



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The European countries and regions are expected to grow at the maximum rate during the forecast period of 2022-2030.

The North American region is expected to dominate the growth scale during the forecast period that will end in 2030.

The market is expected to grow at a CAGR of 14.90% during the period.